138 related articles for article (PubMed ID: 16468640)
1. [Role of Ph-SA in enhancing bactericidal activity of beta-lactam antibiotics].
Tang XY; Zhang J; Guo L; Qiu XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):48-51. PubMed ID: 16468640
[TBL] [Abstract][Full Text] [Related]
2. [Study on in vitro and in vivo antibacterial activity of pheromonicin-SA].
Huang Y; Zhang J; Dai P; Qiu XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):749-52. PubMed ID: 15573744
[TBL] [Abstract][Full Text] [Related]
3. [Impact of Ph-SA on the expression of delta-toxin in Staphylococcus aureus].
Guo L; Zhang J; Tang XY; Qiu XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):312-4. PubMed ID: 15931854
[TBL] [Abstract][Full Text] [Related]
4. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
5. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
[TBL] [Abstract][Full Text] [Related]
7. Screening for highly active beta-lactam antibiotics against Agrobacterium tumefaciens.
Ogawa Y; Mii M
Arch Microbiol; 2004 Apr; 181(4):331-6. PubMed ID: 14752589
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial and toxicological evaluation of beta-lactams synthesized by immobilized beta-lactamase-free penicillin amidase produced by Alcaligenes sp.
Gayen JR; Majee SB; Das S; Samanta TB
Indian J Exp Biol; 2007 Dec; 45(12):1068-72. PubMed ID: 18254214
[TBL] [Abstract][Full Text] [Related]
9. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci.
Zhang HZ; Hackbarth CJ; Chansky KM; Chambers HF
Science; 2001 Mar; 291(5510):1962-5. PubMed ID: 11239156
[TBL] [Abstract][Full Text] [Related]
10. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
11. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus.
Kuroda M; Nagasaki S; Ohta T
J Antimicrob Chemother; 2007 Mar; 59(3):425-32. PubMed ID: 17242033
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus.
Inoue M; Suzuki T; Fujita Y; Oda M; Matsumoto N; Yamase T
J Inorg Biochem; 2006 Jul; 100(7):1225-33. PubMed ID: 16563513
[TBL] [Abstract][Full Text] [Related]
13. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Alou L; Giménez MJ; Sevillano D; Aguilar L; González N; Echeverría O; Torrico M; Coronel P; Prieto J
J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
[No Abstract] [Full Text] [Related]
16. In vitro activity of cefotiam against oxacillin-resistant Staphylococcus epidermidis strains--reevaluation of beta-lactam antibiotics efficiency on MRSE.
Nakamura A; Oguri T; Misawa S; Tabe Y; Kondo S; Miyake K; Miyake N; Igari J; Ohsaka A
Jpn J Antibiot; 2007 Jun; 60(3):153-60. PubMed ID: 17867489
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
Jalil A; Niazi ID; Khan SU
J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
[TBL] [Abstract][Full Text] [Related]
18. Antibiogram and production of beta-lactamase by canine isolates of Staphylococcus aureus.
Engvall A; Wierup M
Nord Vet Med; 1982; 34(1-2):44-8. PubMed ID: 6979034
[TBL] [Abstract][Full Text] [Related]
19. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA).
Murphy JT; Walshe R; Devocelle M
J Theor Biol; 2008 Sep; 254(2):284-93. PubMed ID: 18577389
[TBL] [Abstract][Full Text] [Related]
20. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
